pyrvinium has been researched along with Colorectal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, B; Chen, K; Dai, S; Hu, J; Lv, Y; Shan, L; Zheng, W; Zhu, H | 1 |
| Brussolo, S; Ceccon, M; Gambacorti-Passerini, C; Mologni, L | 1 |
2 other study(ies) available for pyrvinium and Colorectal Cancer
| Article | Year |
|---|---|
Pyrvinium pamoate inhibits cell proliferation through ROS-mediated AKT-dependent signaling pathway in colorectal cancer.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Humans; Proto-Oncogene Proteins c-akt; Pyrvinium Compounds; Reactive Oxygen Species; Signal Transduction | 2021 |
Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colorectal Neoplasms; Drug Synergism; Farnesol; Gene Expression Regulation, Neoplastic; Humans; Mice; Perylene; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Pyrvinium Compounds; ras Proteins; Salicylates; Wnt Proteins | 2012 |